Trulieve Cannabis (TCNNF) Accounts Payables (2020 - 2026)

Trulieve Cannabis' Accounts Payables history runs 7 years deep, the most recent figure standing at $78.9 million for Q1 2026.

• In Q1 2026, Accounts Payables fell 13.4% year-over-year to $78.9 million; the TTM figure through Mar 2026 stood at $78.9 million (down 13.4% YoY), while the FY2025 annual figure was $82.7 million, down 12.1% from the prior year.
• Accounts Payables was $78.9 million for Q1 2026 at Trulieve Cannabis, down from $82.7 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $96.1 million in Q3 2024 to a low of $14.6 million in Q1 2022.
• Historically, Accounts Payables has averaged $81.1 million across 5 years, with a median of $83.2 million in 2023.
• Biggest YoY gain for Accounts Payables was 855.76% in 2022; the steepest drop was 65.18% in 2022.
• A 5-year view of Accounts Payables shows it stood at $82.0 million in 2022, then grew by 1.39% to $83.2 million in 2023, then gained by 13.08% to $94.0 million in 2024, then slipped by 12.1% to $82.7 million in 2025, then slipped by 4.51% to $78.9 million in 2026.
• The last three Accounts Payables figures came in at $78.9 million (Q1 2026), $82.7 million (Q4 2025), and $81.3 million (Q3 2025), per Business Quant data.